SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Oscient Pharmaceuticals Corp. (OSCI)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Peter Shaw who wrote (81)10/9/1996 9:04:00 AM
From: Robert S. Johnson   of 1154
 
I am holding some $7/share GENE stock...... and was interested
in other thoughts on this company. I cannot fathom why this
company which will earn 6-9 cents a share this year is only
at $7/share, while a company like Incyte Pharmaceutical, which
has yet to make any profits, is at $50 per share. My cursory review
showed these companies had several characteristics in common......
so is GENE really a $40-50 stock, or is Incyte Phamaceutical really
a $7 share stock in disguise?

Thanks.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext